Chlamydia pneumoniae infection and atherosclerotic coronary disease

American Heart Journal

Volumn 137, Issue 6, 1999, Pages 1116-1119

  Sessa, Rosa ^a   Di Pietro, Marisa ^b   Santino, Iolanda ^b   Del Piano, Massimo ^b   Varveri, Antonio ^b   Dagianti, Armando ^b   Penco, Maria ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACUTE HEART INFARCTION; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 0033452533     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70371-6     Document Type: Article

References (29)

1. Osler W. Diseases of the arteries. In: Osler W, editor. Modern medicine: its practice and theory. Philadelphia, Pa: Lea & Febiger; 1908. p 429-47.
2. Mattila KJ. Viral and bacterial infections in patients with acute myocardial infarction. J Intern Med 1989;225:293-6.
3. Cook PJ, Lip GYH. Infections agents and atherosclerotic vascular disease. Q J Med 1996;89:727-35.
4. Ellis RW. Infection and coronary heart disease. J Med Microbiol 1997;46:535-9.
5. Grayston JT, Kuo CC, Campbell LA, et al. Chlamydia pneumoniae sp nov for chlamydia strain TWAR. Int J Syst Bacteriol 1989;39:88-90.
6. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae, strain TWAR. J Infect Dis 1990;161:618-25.
7. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multicenter study of 395 cases. Medicine 1990;69:307-16.
8. Grayston JT, Aldous MB, Easton A, et al. Evidence that Chlamydia pneumoniae causes pneumoniae and bronchitis. J Infect Dis 1993;168:1231-5.
9. Gaydos CA, Eiden JJ, Oldach D, et al. Diagnosis of Chlamydia pneumoniae in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. Clin Infect Dis 1994;19:157-60.
10. Karvonen M, Tuomilehto J, Pitkaniemi J, et al. Chlamydia pneumoniae IgG antibody prevalence in South Western and Eastern Finland in 1992 and 1987. Int J Epidemiol 1994;23(1):176-83.
11. Thom DH, Grayston JT. Infections with Chlamydia pneumoniae strain TWAR. Clin Chest Med 1991;12:245-56.
12. Saikku P, Leinonen M, Tenkanem L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;116(4):273-8.
13. Karvonen M, Tuomilehto J, Pitkaniemi J, et al. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987. Epidemiol Infect 1993;110:349-60.
14. Saikku P, Leinonen M, Mattila K, et al. Serologic evidence of an association of a novel Chlamydia, TWAR, with coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
15. Thom DH, Wang SP, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991;11:547-51.
16. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaque. S Afr Med J 1992;82:158-61.
17. Kuo CC, Gowwn AM, Benditt EP, et al. Detection of Chlamydia pneumoniae in aortic lesion of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993;13:1501-4.
18. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae (TWAR) in human coronary atherectomy tissue. J Infect Dis 1995;172:585-8.
19. Grayston JT, Kuo CC, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
20. Blasi F, Cosentini R, Raccanelli R, et al. A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 1997;112:309-12.
21. Kuo CC, Jackson LA, Campbell LA, et al. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-61.
22. Cook PJ, Honeybourne D, Lip GYH, et al. Chlamydia pneumoniae and acute arterial thrombotic. Circulation 1995;31:48-9.
23. Mendall MA, Carrington D, Strachan D, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect 1995;30:121-8.
24. Braun J, Laitko S, Treharne J, et al. Chlamydia pneumoniae: a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994;53:100-5.
25. Socan M, Beovic B, Kese D. Chlamydia pneumoniae and meningoencephalitis. N Engl J Med 1994;231:406.
26. Lindeberg G, Eklund GA, Gullberg B, et al. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991;302:143-6.
27. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-4.
28. Laurila A, Bloigu A, Nayha S, et al. Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross-sectional study. BMJ 1997;314:1456-7.
29. Laurila A, Bloigu A, Nayha S, et al. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:2910-3.